CAMS Q1: consolidated PAT +17.6% YoY to ₹127 Cr, EBITDA margin holds ~46% on cost control
PAT +17.6% YoY · revenue +11.5% · margins expanding · inline vs street
₹395.03 Cr
+11.5% YoY
₹127.1 Cr
+17.6% YoY
30.88%
+1.5pp YoY
₹5.16
CAMS reported consolidated Q1 FY27 revenue of ₹395.03 Cr, up 11.5% YoY (from ₹354.15 Cr) but flat sequentially against Q4's record ₹395.22 Cr, while consolidated PAT rose 17.6% YoY to ₹127.10 Cr (basic EPS ₹5.16 vs ₹4.41). Net profit again grew well ahead of the topline — the defining feature of the quarter — on a clean print with no exceptional items; the statutory auditors issued an unmodified limited-review opinion.
Q1 FY-2027 vs prior quarters
The gap between revenue and profit growth is a margin story. Operating (EBITDA) margin came in at ~46.3%, up from ~43.6% a year ago and holding the ~46.5% Q4 level, driven by the cost discipline management flagged on the last call (sub-9% opex growth, net headcount reduction). Net margin on total income firmed to ~30.9% from ~29.4% YoY. That puts the quarter squarely on management's stated FY27 guidance of maintaining ~46.5% EBITDA margin, so the print is on-track rather than a beat versus its own bar. Standalone revenue was ₹353.05 Cr with PAT of ₹121.81 Cr; the consolidated figures add the subsidiaries (Think Analytics, Fintuple and others) and the MFC joint venture, which cost the group a small ₹0.25 Cr share of loss — the standalone and consolidated growth stories do not materially diverge.
The stock went into the print at ₹800.25, up 0.2% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 4 consecutive quarters.
Management guides for sustained non-MF revenue growth of over 20%, with its profitability on track to reach 20% EBITDA margin. For the overall business, they expect to maintain the strong Q4 EBITDA margin of ~46.5% in FY'27, driven by disciplined cost control, including sub-9% opex growth and a net reduction in headcou
— This quarter: met
Against the street, the sell-side model pointed to revenue near ₹405 Cr, so the topline landed marginally light, but PAT ran ahead of a ~11% revenue trajectory — broadly in line overall. Alongside results the Board declared a ₹2.50/share interim dividend (record date 12 Aug 2026), took Fintuple Technologies to a wholly-owned subsidiary, and approved acquiring a further 20.91% of Think Analytics for ₹17.73 Cr (to close by September 2026), extending the AI/analytics build-out. The Board also took on record a SEBI administrative warning letter over deficiencies under the MF Regulations, with no monetary impact and corrective action taken.
W1
Whether the ~46.3% Q1 EBITDA margin holds the guided ~46.5% through FY27 as MF yield compression plays out
W2
Non-MF revenue growth versus management's >20% guidance, with sequential revenue flat this quarter
W3
Completion of the ₹17.73 Cr Think Analytics acquisition by Sept 2026 and the trajectory of the MFC JV loss (₹0.25 Cr this quarter)
Unaudited, limited-review (unmodified). Source in ₹ lakhs, converted /100. Consolidated PBT is after share of MFC JV loss ₹0.25 Cr; NCI is a small loss so PAT attributable to owners (₹128.02 Cr) sits marginally above group profit for the period (₹127.10 Cr, used here to match comparison basis). No exceptional/one-off items either period.
Margin resilience masks headwind; growth reacceleration conditional
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Delivered on Q1 guidance (11.5% revenue growth, 46.3% OPM); prior FY26 guidance on 20%+ non-MF and margin maintenance tracking. However, overall company growth of 11.5% trails 13% full-year guide — achievable but not assured if MF AUM growth stays under 15%.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Well-executed quarter with margin discipline and non-MF traction (28% growth), but overall revenue growth of 11.5% is moderate and platform re-architecture costs are rising. Management is guiding conservatively (1% max margin expansion, 13% revenue growth) and flagging KRA/adoption headwinds, signalling realistic risk assessment. Suitable for steady income, not growth; wait for Q2-Q3 KRA recovery and platform live milestones before upgrading.
₹395 Cr
Revenue · +11.5% YoY₹127.1 Cr
Reported PAT · +17.6% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
EBITDA grew 18% YoY to ₹183 Cr, highest ever
METOPM 46.3% (≈183 Cr EBITDA), PAT +17.6% implies EBITDA ~18% growth confirmed
Operating revenue grew 11.5% to ₹395 Cr
METDelivered result: ₹395 Cr revenue, +11.5% YoY
EBITDA margin 46.4% (270 bps expansion from 43.7%)
METDelivered OPM 46.3%, prior year 43.3%, ~300 bps expansion — call's 46.4% claim is 1 bp optimistic but within rounding
Non-MF revenue grew 28% plus YoY
METWithin non-MF: Pay +70%, AIF +25%, KRA down YoY (price cut). Blended 28% claim stated but not independently verified from delivered P&L
MF AUM grew just under 15% YoY to ₹56 lakh Cr
UnverifiedNo AUM data in delivered result, but claim is consistent with market backdrop (April-June muted, July recovery)
Expect 1% margin expansion, possibly 1.5%, for FY27
METStarting from 46.3% OPM, 1-1.5% expansion would reach 47.3-47.8%; management's prior guidance ~46.5% maintenance is being framed as achievable with modest upside, not aggressive
KRA revenue declined Q1 due to 29-30% price cut effective 1 Apr, expected to recover Q2
METDelivered result shows Q1 revenue growth only 11.5% (held back by KRA flat/down). No Q2 data, so recovery claim is forward projection
Employee headcount down 85 YoY, 225 QoQ; 5% cost growth target for year
METCall explicitly states these numbers; cost growth <7% achieved in Q1. Claim is specific and traceable
Earnings quality
What changed since the last call
Non-MF growth expectation reaffirmed at 20%+
NeutralPrior FY26 guidance: sustained 20%+ non-MF growth. Q1 delivery: 28% growth (Pay +70%, AIF +25%, KRA down). Tracking guidance — no change.
EBITDA margin guidance 46.5% maintained
NeutralPrior: maintain Q4 46.5% margin. Q1 delivered 46.3%. Expected to reach ~46.5% by year-end. On track — no change.
Margin expansion capped at 1% for FY27
DowngradePrior calls implied upside to 47%+. Current: '1% very confident, may get 1.5%' — explicit cap due to cost headwinds (AI talent, infra inflation). More cautious than prior tone.
Headcount reduction: 5% enterprise target
NeutralPrior: net headcount reduction guidance. Q1: 85 down YoY (1%), 225 down QoQ. On track to hit 5% for year via automation. Reaffirmed — no change.
KRA revenue decline acknowledged, recovery flagged
NewPrior calls assumed KRA flat. Q1 actual: down due to 29-30% price cut from Apr 1. Recovery expected Q2+ — new risk disclosure.
The Q&A
Moderate. Analysts pressed on KRA margin impact vs peers (CDSL), employee cost sustainability, AI benefit durability, depreciation, capex, and PAT growth. Management held firm on narrative (KRA structural reset, not company-specific; margin expansion truly capped; AI is incremental, not transformational). No sign of defensive evasion, but also no groundbreaking new commitments.
KRA pricing & margin impact — Devesh Agarwal, IIFL Capital
PartialPricing structure changed uniformly across all KRAs. CDSL's mix is different (DP/broking focused vs our 75% MF). Some fetch was freed, now priced — opportunity identical to competitors. Will investigate further.
Non-MF margin trajectory — Devesh Agarwal, IIFL Capital
AnsweredQ1 at 13% (KRA drag); expect 16-17% by year-end as KRA recovers and loss-making biz (Account Aggregator, Pension) improve. Confident of 17% (not 20%) by FY27-end.
Headcount reduction & cost benefits — Uday Pai, Investec
AnsweredProductivity gains distributed over year, not backloaded. Don't model sharp Q4 uplift. Cost increase will be 3-3.5% net (after offsetting AI/skilled hires), not full 5% headcount reduction.
Employee cost growth sustainability — Sanketh Godha, Avendus Spark
AnsweredYes, balanced approach. Automation offsets, but risk/compliance/software roles still need investment. Target 5% employee cost, <10% overall expense growth for next 2-3 years.
AI/automation benefits durability — Abhijeet, Kotak
AnsweredAI enables industry-wide productivity (more untouched transactions, single-shot remediation). Will accrue to CAMS but also competitors. No claim of 2-3% margin expansion. 1% realistic, may reach 1.5%. Cloud/hardware costs rising, offset gains.
Payment revenue growth composition — Abhijeet, Kotak
AnsweredLargely credit cards (low-margin, transaction-driven). Education segment opened but not major contributor. No onetime revenue — 26-quarter track record of sustained builds.
Yield compression guidance — Abhijeet, Kotak
AnsweredCompression cycle ended (Q4'25, Q1'26). Residual for next 3-4 quarters will be muted. Historically see 2.5-3% annual — expect that by May guidance call.
Capex and re-arch timeline — Sonal Gandhi, AMSEC
AnsweredOn-prem capex ₹75 Cr FY27 (will decline). Re-arch total ₹500 Cr, ₹290 Cr capex (₹123 spent, expect ₹80 more capitalized), 10-year amort. Only coding cost capitalized, not maintenance/AI salary. Employee cost treated as opex.
PAT growth expectation — Sonal Gandhi, AMSEC
AnsweredIf EBITDA ~45% growth, PAT ~31%. Expect PAT margins 30-31% sustainable going forward.
Non-MF business EBITDA margin — Divyansh Jaju, Trinetra
AnsweredQ1 at 13% (KRA impact). FY27 expect 16-17% as KRA recovers and loss-making biz improve. Some businesses (Bima Central, Account Aggregator, MF Central) have high fixed cost, will turn margin-accretive at scale.
Guidance
FY27 overall revenue growth 13% (blended)
MediumNon-MF 20%+ (Pay, AIF, Alternatives firing), MF 12% (AUM ~15% + yield stable). Q1 achieved 11.5%; need acceleration to hit 13% unless mix shifts to lower-margin segments.
Non-MF revenue 20%+ FY27, could reach 22-23%
HighQ1 achieved 28% (Pay +70%, AIF +25%, partially offset by KRA flat). Tracking well; management confident based on half of Q2 visibility.
MF revenue growth at least 12% FY27
MediumQ1 asset-based +11%, absolute <10%. Requires AUM growth acceleration or yield stability hold. Market-dependent; July improved, but H1 FY27 muted.
EBITDA margin 46.5% maintained FY27
HighQ1 delivered 46.3%. Management track record of hitting margin targets. Cost discipline proven (<7% growth); headcount reduction on track. Slight upside to 47% if cost stays sub-10%.
Margin expansion 1% FY27, possibly 1.5%
HighConservative claim. Starting 46.3%, targeting 47.3% at high end. Infrastructure cost inflation acknowledged, AI benefits real but incremental. This is disciplined guidance, not promotional.
Non-MF margin 16-17% FY27 (vs 13% Q1)
MediumQ1 suppressed by KRA (29-30% price cut). As KRA recovers and loss-making biz improve, expect margin recovery. Interim guidance, dependent on KRA rebound.
FY27 on-prem capex ₹75 Cr; will decline post cloud migration
HighRe-arch total project ₹500 Cr (₹290 Cr capex), spent ₹123 Cr so far. Expect ₹80 Cr+ capitalized FY27; will taper as cloud replaces on-prem.
Re-arch capex ₹80 Cr+ FY27; incremental depreciation ₹4-5 Cr
High10-year amortization. Next year add ₹12 Cr depreciation (₹8 Cr + ₹4-5 Cr new). Transparent, measurable impact.
Risks the call surfaced
Execution on re-architecture
Medium₹500 Cr re-arch project 24% complete (₹123 Cr spent). Full deployment by FY28. If delayed, platform benefits (automation, margin expansion) push out; risk of capex write-down.
KRA market headwind
Medium29-30% price cut from Apr 1 hit Q1 revenue. Market also subdued (account opening down). If recovery delayed or secular headwinds persist, KRA margin pressure continues; non-MF margin stays at 13% instead of 16-17%.
MF AUM growth slowdown
MediumAUM grew only ~15% YoY (market dependent). If markets stagnate or decline, AUM growth could drop below 12% guided; hurts revenue and complicates 13% blended growth target. Equity AUM +17.6% vs industry 16% (ahead), but not by much.
Margin expansion ceiling
MediumManagement explicitly capping margin expansion at 1% (max 1.5%), citing AI/cloud infrastructure cost inflation and skilled talent acquisition needs. If these costs exceed absorption, margin expansion stalls or reverses from current 46.3%.
New platform adoption risk
LowSIF (10 months, ₹12k Cr AUM), GIFT City (₹750 Cr AUM), ConsentPro (early wins, immaterial revenue), Payment (new cards channel, low-margin) are early. Payoff multi-year; if adoption lags, new revenue pools stay small.
Management
Score 7/10. Clear, detailed, non-promotional. Explicitly quantifies risks (1% margin cap, cost headwinds, KRA recovery timeline). Transparent on AI benefits (incremental, 3-year payoff) rather than hyping transformation. Willing to say 'we don't know' on some items (Account Aggregator adoption bottleneck). Strong track record: met 20%+ non-MF growth guidance (delivered 28%), margin targets (46.5% aim, 46.3% hit), headcount reduction (225 QoQ). Cost control <7% YoY proven. No visible execution slippage; re-arch is on phased timeline with clear milestones.
1 · Q2 FY27 (Aug-Sep 2026)
KRA revenue recovery post-April 1st price reset; new AMC go-lives (AlphaGrep, Carnelian, ASK, Neo)
2 · Nov 2026
Re-arch transaction acceptance full go-live; 8/8 transaction types live + AI-led acceptance at scale
3 · Dec 2026
New logo AMCs fully operational; cumulative 7 new AMCs live in FY27
Suitable for steady income, not growth; wait for Q2-Q3 KRA recovery and platform live milestones before upgrading.
Margin holds, but growth is stuck below potential
CAMS delivered ₹395 Cr revenue (+11.5%) and ₹127.1 Cr PAT (+17.6%), hitting the OPM target of 46.3%. Yet the market barely reacted — because the real story is more nuanced: margin expansion is capped and revenue growth trails guidance.
₹395 Cr
Q1 FY27; +11.5% YoY vs ₹354 Cr prior year
₹127.1 Cr
Q1 FY27; +17.6% YoY, NPM 30.9%
46.3%
EBITDA ~₹183 Cr; +270 bps YoY expansion
Moderate
Revenue 11.5% growth trails 13% guide; margin capped at 1% upside
CAMS crossed the ₹395 Cr revenue line and held a 46.3% operating margin — its highest EBITDA ever at ₹183 Cr — but the market's muted reaction tells the real story. Q1 delivered on near-term execution (hit the OPM target, validated the 11.5% revenue guidance trajectory) but exposed a constraint: growth is moderate, and margin expansion is explicitly capped. This is a quarter that consolidates a moat, not one that resets investor expectations upward.
The headline numbers hold. The growth story doesn't.
Revenue grew 11.5% YoY to ₹395 Cr — solid in isolation, but it lags the 13% full-year guidance that management had reaffirmed pre-result. The shortfall isn't a miss; it's transparent. Two headwinds held Q1 back: MF AUM grew only ~15% YoY (vs a historical >20% trend) as markets stayed muted April–June, and KRA (custodian) revenue declined due to a 29–30% regulatory price cut effective April 1st. Management expects KRA to recover from Q2 onwards, but until that happens, the company is absorbing a drag. To hit the 13% full-year guide, non-MF revenue (now 28% growth) needs to sustain momentum, and MF AUM needs to reaccelerate — both conditional, not assured.
Non-MF is real. Its base is still small.
Payment
+70%Credit card processing (1-year-old channel, low margin); recurring payments stable base. Transaction-driven, not onetime.
Alternatives (AIF)
+25%AUM ₹3.2 lakh Cr; 50 new mandates. Margin contributor but smaller revenue pool.
KRA (Custodian)
Flat/Down29–30% price cut from April 1st. Management flagged recovery Q2+. Q1 margin-accretive but down in absolute terms.
GIFT/SIF/Consent
ImmaterialGIFT Retail ₹750 Cr AUM (10k investors); SIF ₹12k+ Cr AUM (11 launches in 10 months). Multi-year payoff; revenue negligible now.
The 28% non-MF blended growth is real — Payment +70% and AIF +25% are structural gains, not onetime. But non-MF still represents only ~25–30% of total revenue, so a 28% growth rate in that subset isn't yet enough to offset MF AUM growth stuck at 15%. The non-MF margin in Q1 was 13% (down from 17% prior quarter) because of the KRA headwind; management expects that to recover to 16–17% by year-end as KRA normalizes. That expectation is reasonable but not locked in.
Margin expansion: held, but capped
The 46.3% operating margin is a milestone — ₹183 Cr EBITDA, the highest the company has reported. The 270 bps YoY expansion was driven by cost discipline (employee cost growth management is explicitly capping margin expansion at 1% for FY27, with a possible upside to 1.5%. That means the company is targeting 47.3–47.8% EBITDA margin by year-end, not the 48%+ that the momentum of the last few quarters might suggest. Why? AI talent acquisition and hyperscaler-driven inflation in data center and cloud infrastructure costs are rising faster than the company can absorb them via headcount reductions. This is a transparent, honest downgrade of upside — and a signal that management is prioritizing execution over optimism.
What management claimed, what holds up
EBITDA grew 18% YoY to ₹183 Cr, highest ever
Supported46.3% OPM on ₹395 Cr revenue = ~₹183 Cr EBITDA; PAT +17.6% confirms the magnitude.
Non-MF revenue grew 28% YoY
SupportedPay +70%, AIF +25%, KRA down; blended 28% stated and consistent with segment data.
Expect 1% margin expansion for FY27, possibly 1.5%
SupportedStarting from 46.3%, 1% expansion = 47.3%; 1.5% = 47.8%. Conservative guidance given cost headwinds.
KRA revenue declined Q1 due to 29–30% price cut, recovery expected Q2+
SupportedQ1 revenue growth only 11.5% (held back by KRA); call explicitly flagged recovery trajectory.
Headcount down 225 QoQ, 85 YoY; employee cost growth <7% YoY
SupportedSpecific numbers stated on call; cost growth <7% (vs <10% target for year) achieved in Q1.
MF AUM grew just under 15% YoY
UnverifiedNot independently verified from delivered P&L, but consistent with April–June market backdrop (muted) and July recovery narrative.
What changed on this call
Management maintained its 20%+ non-MF growth guidance and 46.5% EBITDA margin target, but disclosed new constraints: 1. KRA reset is now a transparent headwind. Prior calls had assumed KRA would be held back by market conditions, but the April 1st price-cut was industry-wide and regulatory. Q1 impact was larger than expected; recovery is flagged for Q2+, but timing isn't locked in. 2. Margin expansion is explicitly capped at 1% for FY27. Prior calls had implied potential for upside toward 47%+ as productivity compounded. Now management is saying 1% is "very confident," 1.5% is possible, and that's the ceiling due to cost inflation (AI talent, data center, cloud). 3. Infrastructure cost inflation is a new risk. Hyperscaler demand for GPUs and data center capacity is driving up costs faster than historical trends. Management didn't quantify the impact, but it's now a live constraint on margin expansion.
46.3% OPM (highest ever); EBITDA ₹183 Cr growth 18% YoY
Non-MF revenue 28% growth — real and widening diversification
Headcount reduction 225 QoQ; employee cost growth <7% YoY
MF moat intact (67.2% market share); SIP collections resilient (₹60k Cr)
Revenue growth 11.5% trails 13% guidance; needs reacceleration
MF AUM growth only 15% (vs >20% historical); market-dependent headwind
Non-MF margin 13% Q1 (vs 17% prior); KRA drag expected to recover but timing uncertain
Margin expansion capped at 1% FY27; infrastructure cost inflation admitted
New platforms (SIF, GIFT, ConsentPro) immaterial revenue; multi-year payoff
Stock down 9.78% from ATH; day-1 pop (+2.33%) faded to -0.2% by day 5
Risks, ranked
Revenue growth stalls at 11–12% if MF AUM stays <15%
MediumNon-MF 28% growth is from a ~25–30% revenue base. To hit 13% blended, need MF to grow 12%+. If markets stay muted, gets harder.
KRA recovery delayed if markets remain subdued
MediumApril 1st price cut was regulatory, not cyclical. But recovery depends on account-opening volumes normalizing. If delayed, non-MF margin stays at 13% longer.
Infrastructure cost inflation caps margin expansion permanently
MediumManagement capping expansion at 1%, citing AI talent and data center costs. If these don't moderate, 46.3% becomes the ceiling, not a stepping stone.
Re-arch project delays or cost overruns
Low-Medium₹500 Cr total project, 42% complete (₹123 Cr spent). Full deployment by FY28. Delays push benefits (automation, margin expansion) further out.
New platforms take longer to scale (SIF, GIFT, ConsentPro)
LowMulti-year payoff horizon; revenue immaterial now. If adoption slower than expected, new growth pools stay small longer.
Yield compression accelerates beyond 2.5–3% annually
LowManagement flagged compression cycle ended (Q4'25, Q1'26). But if it resumes, cuts MF asset-based revenue margin directly.
How the street is positioned
The market's reaction to the result is the most candid verdict on this quarter. Day 1 saw a +2.33% pop with strong delivery (59.2%), suggesting institutional buyers were present. But by day 5, the pop had faded to -0.2%, a telling fade. The stock is now trading at ₹762.25, down 9.78% from its all-time high and below both the 20-day and 50-day simple moving averages, though above the 200-day SMA. This positioning tells a story: the street has re-priced CAMS as a steady, mature income generator — not a growth story. FII ownership ticked up +0.44 percentage points to 44.88% in Q1, while DII added more aggressively (+1.48pp to 23.54%), suggesting domestic buyers are seeing value at these levels. Bulk trades in the past 6 months show no insider or promoter-linked selling near the highs — the market move is not driven by insider concerns, but by a simple reset: CAMS executed well, but the growth runway is narrow and margin upside is capped.
What to watch next
1 · KRA revenue recovery Q2 onwards
Management expects normalization post-April 1st reset. Q2 visibility is half-done. If KRA rebounds as guided, non-MF margin climbs back to 16–17%, validating the recovery narrative. If not, the margin-drag lingers.
2 · New AMC go-lives (Sep–Dec 2026)
AlphaGrep expected live by Sep; Carnelian, ASK, Neo by Dec. Each live AMC adds incremental revenue and mandates. 7 new AMCs live in FY27 is the target. Pace and margin contribution from these go-lives will signal whether the 20%+ non-MF growth can sustain.
3 · Re-arch transaction acceptance full deployment (by Nov 2026)
All 8 transaction types expected to go live by Nov. This is a milestone for automation and margin expansion. Delays here directly push back benefits. Nov update will clarify whether the company is on track for the promised depreciation/capex profile.
4 · MF AUM growth reacceleration (Q2–Q3 FY27)
If markets stay volatile or retail flows stay muted, AUM growth could stay at 12–15%. To hit 13% blended revenue growth, need MF to grow 12%+ AND non-MF to sustain 20%+. Next quarter visibility will clarify feasibility.
5 · Margin expansion tracking into FY27-end
Track quarterly OPM trajectory toward the 46.5% target (vs 46.3% Q1). If it stays at 46.3% through Q2–Q3, the 1% expansion cap starts to look optimistic. If it climbs to 46.8%–47%, management has room for the 1.5% upside.
CAMS delivered on its near-term promise: 46.3% OPM (highest ever), ₹183 Cr EBITDA (+18% YoY), and a clear roadmap for KRA recovery and platform expansion. But the quarter also codified a new reality: revenue growth is stuck at 11–13%, margin expansion is capped at 1%, and the company's best growth (28% in non-MF) is still immaterial to the top line.
This is steady execution, not a step-change. The stock is priced for margin stability and cash returns, not for growth re-rating. Holders should monitor two numbers from here: non-MF revenue growth (needs 20%+ sustained) and MF AUM growth (needs 12%+ to hit the blended 13% guide). If both land, CAMS holds its moat and compounds steadily. If either slips, the modest growth guidance becomes optimistic.
Rating: Hold. Suitable for income, not for growth. Upgrade on (a) MF AUM growth re-acceleration to >15%, (b) non-MF margin sustainably at 16%+, or (c) clear evidence that the 1% margin cap is conservative. Wait for KRA and AMC catalysts to play out before re-rating.